Skip to search formSkip to main contentSkip to account menu

Insulin Glargine

Known as: INSULIN,GLARGINE,HUMAN/rDNA, Glargine, Insulin, Insulin, Glycyl(A21)-Arginyl(B31,B32) 
A recombinant human insulin analog with long-acting, blood glucose-lowering activity. Insulin glargine, like regular types of human insulin… 
National Institutes of Health

Related topics

Related topics

20 relations
1.5 ML Insulin Glargine 300 UNT/ML Pen Injector [Toujeo]3 ML Insulin Glargine 100 UNT/ML Pen Injector [Lantus]Decreased Lipolysis [PE]Diabetes Mellitus, Insulin-Dependent

Narrower (4)

HOE 901LY2963016 insulin glargineLantusSoliqua

Broader (1)

Hypoglycemic Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Comparison of Insulin Glargine 300 U / mL and 100 U / mL in Adults With Type 1 Diabetes : Continuous Glucose Monitoring Profiles and Variability Using Morning or Evening Injections
In this 16-week, exploratory, open-label, parallel-group, two-period crossover study (clinicaltrials.gov identifier NCT01658579… 
Highly Cited
2014
Highly Cited
2014
Basal Insulin Peglispro Demonstrates Preferential Hepatic Versus Peripheral Action Relative to Insulin Glargine in Healthy Subjects
OBJECTIVE We evaluated the endogenous glucose production (EGP) and glucose disposal rate (GDR) over a range of doses of basal… 
Highly Cited
2011
Highly Cited
2011
A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure.
OBJECTIVE To determine whether 1 or 2 preprandial injections before the meals of greatest glycemic impact can be as effective as… 
Review
2008
Review
2008
Combining insulins with oral antidiabetic agents: effect on hyperglycemic control, markers of cardiovascular risk and disease
Patients with type 2 diabetes mellitus (T2DM) have an increased risk of cardiovascular disease (CVD). Unfortunately, several… 
Review
2008
Review
2008
Addition of Neutral Protamine Lispro Insulin or Insulin Glargine to Oral Type 2 Diabetes Regimens for Patients with Suboptimal Glycemic Control
Context Bedtime insulin is a common strategy for improving glycemic control when type 2 diabetes is poorly controlled with oral… 
Review
2007
Review
2007
Adding Insulin Glargine Versus Rosiglitazone
OBJECTIVE—We sought to assess health-related quality of life (HRQOL) in patients with type 2 diabetes treated with insulin… 
Highly Cited
2007
Highly Cited
2007
Combination of Oral Antidiabetic Agents with Basal Insulin Versus Premixed Insulin Alone in Randomized Elderly Patients with Type 2 Diabetes Mellitus
OBJECTIVES: To compare initiation of insulin therapy by adding once‐daily insulin glargine to oral antidiabetic agents (OADs… 
Review
2005
Review
2005
Efficacy of biphasic insulin aspart in patients with type 2 diabetes.
Review
2002
Review
2002
Novel insulins: expanding options in diabetes management.
Highly Cited
2002
Highly Cited
2002
Use of Insulin Glargine During Pregnancy in Seven Type 1 Diabetic Women
The patient was a 37-year-old registered nurse recently followed during her second pregnancy complicated by diabetes. Type 1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)